Related Experiment Video
Updated: May 20, 2026
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
No harmful effect of mycophenolate mofetil on liver regeneration: an experimental study
M Demiray1, H F Kucuk, M Yildirim
1Department of General Surgery, Kartal Research and Education Hospital, Kartal-Istanbul, Turkey.
Aim:
The aim of this experimental study was to examine the effects of mycophenolate mofetil (MMF) on liver regeneration in a partial hepatectomy model.
Methods:
Rats were divided into 3 groups immediately following partial liver resection: saline, controls intraperitoneally (MMF; Group 1); MMF (15 mg/kg/d; Group II), and MMF (30 mg/kg/d; Group III). On days 3 and 7 following liver resection we humanely killed half of the rats in each group to measure alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels and to evaluate Ki-67 using immunohistochemistry. We calculated liver regeneration rates.
Results:
The difference between ALT levels on days 3 and 7 was not significantly different among the groups (P = .157; P = .292; P > .05, respectively). The AST levels were significantly different at 3 days (P = .018) but not 7 days (P = .385). The Ki-67 level were different among groups at day 3 (P = .002) but not at day 7 (P = .290). Liver regeneration rates were not different among the groups either at 3 or at 7 days (P = .264 and P = .925, respectively).
Conclusion:
MMF stimulates mitosis but its effect on regeneration is not clear. MMF appeared to show no adverse effects on liver regeneration.
Insights
Mycophenolate mofetil (MMF) did not significantly impact liver regeneration rates after partial hepatectomy in rats. While MMF showed some effects on cell proliferation markers, it did not adversely affect overall liver regeneration.
Area of Science:
- Hepatology
- Immunology
- Surgical Research
Background:
- Partial hepatectomy is a common surgical procedure.
- Liver regeneration is a complex biological process crucial for recovery.
- Immunosuppressants like mycophenolate mofetil (MMF) are used in various medical conditions, but their impact on liver regeneration requires investigation.
Purpose of the Study:
- To investigate the effects of mycophenolate mofetil (MMF) on liver regeneration following partial hepatectomy in a rat model.
- To assess the impact of different MMF dosages on key liver function markers and cellular proliferation.
Main Methods:
- A partial hepatectomy was performed on rats, followed by administration of saline (control) or two different doses of MMF.
- Liver regeneration was evaluated on days 3 and 7 post-surgery by measuring alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels.
- Ki-67 immunohistochemistry was used to assess cell proliferation, and liver regeneration rates were calculated.
Main Results:
- No significant differences in ALT levels were observed among the groups at days 3 and 7.
- AST levels showed a significant difference at day 3 but not at day 7.
- Ki-67 levels were significantly different at day 3, indicating stimulated mitosis, but not at day 7. Liver regeneration rates did not differ significantly among groups.
Conclusions:
- Mycophenolate mofetil (MMF) appears to stimulate mitosis in the liver but its direct effect on the overall regeneration process remains unclear.
- MMF did not demonstrate adverse effects on liver regeneration rates in this partial hepatectomy model.
- Further research is warranted to fully elucidate the role of MMF in liver regeneration.
Related Concept Videos
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test